A senior Portfolio Management leader with extensive experience in portfolio planning, management and operations in global pharmaceutical organizations. Designs, implements and oversees best practices, processes, analytical methods and tools. Effectively manages stakeholders. Builds high performing multi-disciplinary teams and drives consensus in cross functional teams across R&D, Commercial, and Finance. Engaged as a subject matter expert in Portfolio Management to speak at industry conferences.CORE CAPABILITIES • Portfolio management – managing project portfolio activities across therapy areas through structured reviews • Project prioritization and portfolio optimization – applying qualitative and quantitative ranking methodologies to select investments under constraints • Stage gate review process – building processes to facilitate “Go/No Go” decisions • Process improvement – implementing portfolio management best practices and systems • Project management – planning and leading cross functional teams to achieve strategic goals • Decision analysis – analysis of options and recommending the best option for product development • Risk analysis – risk decomposition using decision trees to quantify product and program risks • P&L – forecasting and budgeting with responsibility for department P&Ls • Valuations and financial modeling – population and analogue based financial modeling to evaluate pipeline potential and M&A opportunity assessment using risk adjusted net present value and internal rate of return • Strategic planning – aligning portfolio planning with company goals and growth objectives • Commercial analysis – primary market research and market analytics • Employee development – developing and supervising key talent